These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 33116817)

  • 1. Biomarkers for Inflammatory Breast Cancer: Diagnostic and Therapeutic Utility.
    Dobiasova B; Mego M
    Breast Cancer (Dove Med Press); 2020; 12():153-163. PubMed ID: 33116817
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inflammatory breast cancer biology: the tumour microenvironment is key.
    Lim B; Woodward WA; Wang X; Reuben JM; Ueno NT
    Nat Rev Cancer; 2018 Aug; 18(8):485-499. PubMed ID: 29703913
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deciphering the role of interferon alpha signaling and microenvironment crosstalk in inflammatory breast cancer.
    Provance OK; Lewis-Wambi J
    Breast Cancer Res; 2019 May; 21(1):59. PubMed ID: 31060575
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting Signaling Pathways in Inflammatory Breast Cancer.
    Wang X; Semba T; Phi LTH; Chainitikun S; Iwase T; Lim B; Ueno NT
    Cancers (Basel); 2020 Sep; 12(9):. PubMed ID: 32883032
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inflammatory Breast Cancer Promotes Development of M2 Tumor-Associated Macrophages and Cancer Mesenchymal Cells through a Complex Chemokine Network.
    Valeta-Magara A; Gadi A; Volta V; Walters B; Arju R; Giashuddin S; Zhong H; Schneider RJ
    Cancer Res; 2019 Jul; 79(13):3360-3371. PubMed ID: 31043378
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The immunogram of inflammatory breast cancer.
    Valenza C; Trapani D; Fusco N; Wang X; Cristofanilli M; Ueno NT; Curigliano G
    Cancer Treat Rev; 2023 Sep; 119():102598. PubMed ID: 37437342
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hyperactivated mTOR and JAK2/STAT3 Pathways: Molecular Drivers and Potential Therapeutic Targets of Inflammatory and Invasive Ductal Breast Cancers After Neoadjuvant Chemotherapy.
    Jhaveri K; Teplinsky E; Silvera D; Valeta-Magara A; Arju R; Giashuddin S; Sarfraz Y; Alexander M; Darvishian F; Levine PH; Hashmi S; Zolfaghari L; Hoffman HJ; Singh B; Goldberg JD; Hochman T; Formenti S; Esteva FJ; Moran MS; Schneider RJ
    Clin Breast Cancer; 2016 Apr; 16(2):113-22.e1. PubMed ID: 26774497
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The tumor microenvironment and inflammatory breast cancer.
    Huang A; Cao S; Tang L
    J Cancer; 2017; 8(10):1884-1891. PubMed ID: 28819386
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inflammatory breast cancer: New factors contribute to disease etiology: A review.
    Mohamed MM; Al-Raawi D; Sabet SF; El-Shinawi M
    J Adv Res; 2014 Sep; 5(5):525-36. PubMed ID: 25685520
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inflammatory breast cancer: The pathologists' perspective.
    Cserni G; Charafe-Jauffret E; van Diest PJ
    Eur J Surg Oncol; 2018 Aug; 44(8):1128-1134. PubMed ID: 29706301
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathological and molecular characteristics of inflammatory breast cancer.
    Di Bonito M; Cantile M; Botti G
    Transl Cancer Res; 2019 Oct; 8(Suppl 5):S449-S456. PubMed ID: 35117122
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inflammatory Breast Cancer: a Separate Entity.
    Rosenbluth JM; Overmoyer BA
    Curr Oncol Rep; 2019 Aug; 21(10):86. PubMed ID: 31414257
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interferon-induced transmembrane protein 1 (IFITM1) overexpression enhances the aggressive phenotype of SUM149 inflammatory breast cancer cells in a signal transducer and activator of transcription 2 (STAT2)-dependent manner.
    Ogony J; Choi HJ; Lui A; Cristofanilli M; Lewis-Wambi J
    Breast Cancer Res; 2016 Feb; 18(1):25. PubMed ID: 26897526
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunotherapy for inflammatory breast cancer: current evidences and future perspectives.
    Valenza C; Trapani D; Curigliano G
    Curr Opin Oncol; 2023 Nov; 35(6):507-512. PubMed ID: 37621167
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identifying the impact of inflammatory breast cancer on survival: a retrospective multi-center cohort study.
    Diessner J; Van Ewijk R; Weiss CR; Janni W; Wischnewsky MB; Kreienberg R; Hancke K; Blettner M; Wöckel A; Schwentner L
    Arch Gynecol Obstet; 2015 Sep; 292(3):655-64. PubMed ID: 25814296
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Systemic treatments of inflammatory breast cancer: an overview].
    Monneur A; Bertucci F; Viens P; Gonçalves A
    Bull Cancer; 2014 Dec; 101(12):1080-8. PubMed ID: 25475708
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intermittent hypoxia confers pro-metastatic gene expression selectively through NF-κB in inflammatory breast cancer cells.
    Gutsche K; Randi EB; Blank V; Fink D; Wenger RH; Leo C; Scholz CC
    Free Radic Biol Med; 2016 Dec; 101():129-142. PubMed ID: 27717868
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Toward precision medicine in inflammatory breast cancer.
    Viale G; Marra A; Curigliano G; Criscitiello C
    Transl Cancer Res; 2019 Oct; 8(Suppl 5):S469-S478. PubMed ID: 35117125
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The combined presence of CD20 + B cells and PD-L1 + tumor-infiltrating lymphocytes in inflammatory breast cancer is prognostic of improved patient outcome.
    Arias-Pulido H; Cimino-Mathews A; Chaher N; Qualls C; Joste N; Colpaert C; Marotti JD; Foisey M; Prossnitz ER; Emens LA; Fiering S
    Breast Cancer Res Treat; 2018 Sep; 171(2):273-282. PubMed ID: 29858752
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PPARgamma: A Potential Intrinsic and Extrinsic Molecular Target for Breast Cancer Therapy.
    Augimeri G; Bonofiglio D
    Biomedicines; 2021 May; 9(5):. PubMed ID: 34067944
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.